Abstract

Traditional carrier screening has been utilized for the detection of carriers of genetic disorders. Since a comprehensive assessment of the carrier frequencies of recessive conditions in the Southern Chinese population is not yet available, we performed a secondary analysis on the spectrum and carrier status for 315 genes causing autosomal recessive disorders in 1543 Southern Chinese individuals with next-generation sequencing data, 1116 with exome sequencing and 427 with genome sequencing data. Our data revealed that 1 in 2 people (47.8% of the population) was a carrier for one or more recessive conditions, and 1 in 12 individuals (8.30% of the population) was a carrier for treatable inherited conditions. In alignment with current American College of Obstetricians and Gynecologists (ACOG) pan-ethnic carrier recommendations, 1 in 26 individuals were identified as carriers of cystic fibrosis, thalassemia, and spinal muscular atrophy in the Southern Chinese population. When the >1% expanded carrier screening rate recommendation by ACOG was used, 11 diseases were found to meet the criteria in the Southern Chinese population. Approximately 1 in 3 individuals (35.5% of the population) were carriers of these 11 conditions. If the 1 in 200 carrier frequency threshold is used, and additional seven genes would meet the criteria, and 2 in 5 individuals (38.7% of the population) would be detected as a carrier. This study provides a comprehensive catalogue of the carrier spectrum and frequency in the Southern Chinese population and can serve as a reference for careful evaluation of the conditions to be included in expanded carrier screening for Southern Chinese people.

Details

Title
Comprehensive analysis of recessive carrier status using exome and genome sequencing data in 1543 Southern Chinese
Author
Chau Jeffrey Fong Ting 1   VIAFID ORCID Logo  ; Yu Mullin Ho Chung 1 ; Chui Martin Man Chun 1   VIAFID ORCID Logo  ; Yeung Cyrus Chun Wing 2 ; Kwok Aaron Wing Cheung 2 ; Zhuang Xuehan 2 ; Lee, Ryan 1 ; Lee Fong, Fung Jasmine 1 ; Lee, Mianne 1 ; Mak Christopher Chun Yu 1   VIAFID ORCID Logo  ; Ng Nicole Ying Ting 1 ; Chung Claudia Ching Yan 1 ; Chan Marcus Chun Yin 1   VIAFID ORCID Logo  ; Tsang Mandy Ho Yin 1 ; Chan Joshua Chun Ki 1   VIAFID ORCID Logo  ; Chan Kelvin Yuen Kwong 3 ; Kan Anita Sik Yau 3   VIAFID ORCID Logo  ; Ho Yu, Chung Patrick 2 ; Yang Wanling 1   VIAFID ORCID Logo  ; Lee, So Lun 4 ; Chan Godfrey Chi Fung 1 ; Tam Paul Kwong Hang 5 ; Lau, Yu Lung 1 ; Yeung, Kit San 1   VIAFID ORCID Logo  ; Hon Yin, Chung Brian 1   VIAFID ORCID Logo  ; Tang Clara Sze Man 5 

 The University of Hong Kong, Department of Paediatrics and Adolescent Medicine, LKS Faculty of Medicine, Hong Kong SAR, China (GRID:grid.194645.b) (ISNI:0000000121742757) 
 The University of Hong Kong, Department of Surgery, LKS Faculty of Medicine, Hong Kong SAR, China (GRID:grid.194645.b) (ISNI:0000000121742757) 
 Tsan Yuk Hospital, Prenatal Diagnostic Laboratory, Department of Obstetrics and Gynaecology, Hong Kong SAR, China (GRID:grid.460837.e) (ISNI:0000 0004 1762 6827) 
 Duchess of Kent Children’s Hospital, Department of Paediatrics and Adolescent Medicine, Hong Kong SAR, China (GRID:grid.414186.e) (ISNI:0000 0004 1798 1036) 
 The University of Hong Kong, Department of Surgery, LKS Faculty of Medicine, Hong Kong SAR, China (GRID:grid.194645.b) (ISNI:0000000121742757); The University of Hong Kong–Karolinska Institute Collaboration in Regenerative Medicine, Li Dak-Sum Research Centre, Hong Kong SAR, China (GRID:grid.194645.b) (ISNI:0000000121742757) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20567944
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2641595189
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.